It can selectively inhibit the intrinsic E1A-associated 300-kDa protein p300 (p300) in HATs, thereby suppressing the expression of AD-related genes PS1 and BACE1 by inhibiting H3 acetylation in their promoter regions [217]. This evidence concerns the gene EP300 and Alzheimer disease.